Month: July 2012

$2 million to study role-switching cells in heart failure

The National Institutes of Health has awarded more than $2 million to a team of scientists from Washington University in St. Louis and InvivoSciences, a biotechnology startup with WUSTL roots, to construct artificial tissue models that will allow the rapid testing of new drugs for heart failure. According to the Centers for Disease Control, about…
Read more